DARE BIOSCIENCE, INC. (DARE)

Every figure this model derived for DARE, the value it took, and the element in the company's own XBRL it was read from — so any of it can be checked against the filing rather than taken on trust. As at 2026-06-30.

The figures, and where each came from

This is the part no other screener shows. Each figure below names the XBRL element it was read from, so it can be checked against the filing itself.

FigureValueXBRL tagAs at
capex 461,929 PaymentsToAcquirePropertyPlantAndEquipment 2026-06-30
cash 12,617,594 CashAndCashEquivalentsAtCarryingValue 2026-06-30
current assets 16,686,163 AssetsCurrent 2026-06-30
current liabilities 16,922,620 LiabilitiesCurrent 2026-06-30
equity -560,100 StockholdersEquity 2026-06-30
ocf -11,293,561 NetCashProvidedByUsedInOperatingActivities 2026-06-30
revenue 1,365,939 RevenueFromContractWithCustomerExcludingAssessedTax 2026-06-30
sbc 1,501,853 ShareBasedCompensation 2026-06-30

The ratios

The figures themselves rather than their scores — what somebody looking up DARE on one particular measure came for.

RatioValue
cash operating margin-547.39
current ratio0.99
current ratio reported0.99
dilution pct31.58
fcf margin-860.62
growth cv1.87
operating margin-813.38
owner earnings margin-970.57
sbc pct revenue109.95

What to be careful about

What this model itself distrusts about DARE's figures. Written by the derivation as it ran, not added afterwards.